Literature DB >> 17213244

The ability of the Biodex Stability System to distinguish level of function in subjects with a second-degree ankle sprain.

Marc Perron1, Luc J Hébert, Bradford J McFadyen, Sylvain Belzile, Mario Regniére.   

Abstract

OBJECTIVE: To assess the capacity of the Biodex Stability System using a one-leg stance protocol to differentiate between injured and non-injured limbs and between level of disabilities.
DESIGN: Cross-sectional study.
SETTING: Military and civilian clinic.
SUBJECTS: Thirty-four individuals with a second-degree lateral ankle sprain and 36 healthy subjects. METHODS AND MEASURES: Subjects were tested on the Stability System 30 days after injury using a one-leg stance protocol in the dynamic limit-of-stability mode. All subjects also filled out a disability questionnaire (Lower Extremity Functional Scale). The groups were compared based on the overall dynamic limit-of-stability score and its relationship with the score on the disability questionnaire was also examined.
RESULTS: The overall dynamic limit-of-stability scores (subjects with a lateral ankle sprain: 13.0% (5.5)-26.0% (9.2); healthy subjects: 16.9% (7.9)-27.9% (9.6)) clustered in the lower end of the theoretical range of 0-100%. Statistically significant differences in the overall dynamic limit-of-stability scores were found between the injured and non-injured limbs but group differences were small and clinically not relevant. No significant relationships were found between the overall dynamic limit-of-stability scores and the Lower Extremity Functional Scale scores (58.2 (11.8)) of the subjects with a lateral ankle sprain.
CONCLUSIONS: The one-leg stance protocol carried out in the dynamic limit-of-stability mode is very challenging and offers a very limited capacity to differentiate between injured and non-injured limbs. The main outcome of the Stability System does not appear to be a good indicator of the functional capacity of people with a lateral ankle sprain.

Entities:  

Mesh:

Year:  2007        PMID: 17213244     DOI: 10.1177/0269215506071288

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  7 in total

1.  [Not Available].

Authors:  Frédéric René; Lynn Casimiro; Manon Tremblay; Lucie Brosseau; Phanny Chea; Liliane Létourneau; Megan Silva; Victoria Stockwell; Louis-Philippe Bergeron
Journal:  Physiother Can       Date:  2011-04-13       Impact factor: 1.037

2.  Uphill and Downhill Walking in Multiple Sclerosis: A Randomized Controlled Trial.

Authors:  Afshin Samaei; Amir Hoshang Bakhtiary; Abdolhamid Hajihasani; Elham Fatemi; Fatemeh Motaharinezhad
Journal:  Int J MS Care       Date:  2016 Jan-Feb

3.  Criteria-Based Return to Sport Decision-Making Following Lateral Ankle Sprain Injury: a Systematic Review and Narrative Synthesis.

Authors:  Bruno Tassignon; Jo Verschueren; Eamonn Delahunt; Michelle Smith; Bill Vicenzino; Evert Verhagen; Romain Meeusen
Journal:  Sports Med       Date:  2019-04       Impact factor: 11.136

Review 4.  Systematic review of motor control and somatosensation assessment tests for the ankle.

Authors:  Michaël Bertrand-Charette; Charline Dambreville; Laurent J Bouyer; Jean-Sébastien Roy
Journal:  BMJ Open Sport Exerc Med       Date:  2020-07-06

5.  Effect of twister wrap orthosis on foot pressure distribution and balance in diplegic cerebral palsy.

Authors:  Mohamed A Eid; Sobhy M Aly; Rasha A Mohamed
Journal:  J Musculoskelet Neuronal Interact       Date:  2018-12-01       Impact factor: 2.041

6.  Efficacy of two intervention approaches on functional walking capacity and balance in children with Duchene muscular dystrophy.

Authors:  Abd El Aziz A Sherief; Heba Gaber Abd ElAziz; Mostafa S Ali
Journal:  J Musculoskelet Neuronal Interact       Date:  2021-09-01       Impact factor: 2.041

7.  Mechanical vestibular stimulation versus traditional balance exercises in children with Down syndrome.

Authors:  Ibrahim M Nahla; Salem Elham El-Sayed; Abd-Elraouf Ehab Ragaa; Abd El Hamid Amr Abd El Ghafar
Journal:  Afr Health Sci       Date:  2022-03       Impact factor: 1.108

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.